Literature DB >> 11045788

Plasma 1,25-dihydroxy- and 25-hydroxyvitamin D and adenomatous polyps of the distal colorectum.

E A Platz1, S E Hankinson, B W Hollis, G A Colditz, D J Hunter, F E Speizer, E Giovannucci.   

Abstract

1,25-dihydroxyvitamin D [1,25(OH)2D] inhibits proliferation and promotes differentiation of human colon cancer cell lines. Epidemiological findings, although not entirely consistent, suggest an inverse relationship between vitamin D intake and colorectal cancer and adenoma, colorectal cancer precursor lesions. We evaluated the relationship of plasma 1,25(OH)2D and 25-hydroxyvitamin D [25(OH)D] with distal colorectal adenoma among 326 matched case and control pairs (nested in the prospective Nurses' Health Study), who provided blood in 1989-1990 and who underwent endoscopy in 1989-1996. Plasma vitamin D metabolite concentrations were determined blindly by RIA. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated from multiple conditional logistic regression models. Mean plasma 1,25(OH)2D and 25(OH)D levels did not significantly differ (P = 0.3 and 0.7, respectively) between cases (31.6 +/- 8.4 pg/ml and 26.4 +/- 10.6 ng/ml, respectively) and controls (32.2 +/- 8.6 pg/ml and 26.8 +/-10.2 ng/ml, respectively). However, women whose plasma 1,25(OH)2D concentration was below 26.0 pg/ml (a level typically considered to be below normal) were at increased risk of distal colorectal adenoma (OR, 1.58; 95% CI, 1.03-2.40). Compared with the lowest 1,25(OH)2D quartile, women in the second (OR, 0.64; 95% CI, 0.41-1.02), third (OR, 0.80; 95% CI, 0.50-1.30), or upper (OR, 0.71; 95% CI, 0.43-1.15) quartiles were at a statistically nonsignificant lower risk of adenoma. The relationship was stronger for large/villous adenoma and among those with consistent vitamin D intake over the 10 years prior to blood draw. Compared with women in the lowest quartile, for plasma 25(OH)D, women in the second (OR, 0.64; 95% CI, 0.41-1.00) and third (OR, 0.58; 95% CI, 0.36-0.95) quartiles were at a statistically significantly lower risk of distal colorectal adenoma, but there was no difference in risk in the top quartile (OR, 1.04; 95% CI, 0.66-1.66). We conclude that women who have low levels of circulating 1,25(OH)2D may be at higher risk of distal colorectal adenomas, but additional study is warranted.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11045788

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  37 in total

1.  Blood 25-hydroxyvitamin D3 concentrations and incident sporadic colorectal adenoma risk: a pooled case-control study.

Authors:  Veronika Fedirko; Roberd M Bostick; Michael Goodman; W Dana Flanders; Myron D Gross
Journal:  Am J Epidemiol       Date:  2010-07-22       Impact factor: 4.897

2.  Increasing longevity by tuning up metabolism. To maximize human health and lifespan, scientists must abandon outdated models of micronutrients.

Authors:  Bruce N Ames
Journal:  EMBO Rep       Date:  2005-07       Impact factor: 8.807

3.  Serum 25(OH)D levels, dietary intake of vitamin D, and colorectal adenoma recurrence.

Authors:  Elizabeth T Jacobs; David S Alberts; Jose Benuzillo; Bruce W Hollis; Patricia A Thompson; María Elena Martínez
Journal:  J Steroid Biochem Mol Biol       Date:  2007-01-12       Impact factor: 4.292

4.  Vitamin D suppresses Th17 cytokine production by inducing C/EBP homologous protein (CHOP) expression.

Authors:  Seon Hee Chang; Yeonseok Chung; Chen Dong
Journal:  J Biol Chem       Date:  2010-10-25       Impact factor: 5.157

5.  Plasma insulin-like growth factor-1 level and risk of incident hypertension in nondiabetic women.

Authors:  Luxia Zhang; Gary C Curhan; John P Forman
Journal:  J Hypertens       Date:  2011-02       Impact factor: 4.844

6.  Vitamin D Deficiency Adds an Element of Risk to Insulin Resistance in Colorectal Neoplasms.

Authors:  Myong Ki Baeg; Myung-Gyu Choi; Sun-Hye Ko; Bo-Geun Park; Kyung-Do Han; Jae Myung Park; Bo-In Lee; In-Seok Lee; Sang-Woo Kim
Journal:  Dig Dis Sci       Date:  2015-04-04       Impact factor: 3.199

7.  The influence of health and lifestyle characteristics on the relation of serum 25-hydroxyvitamin D with risk of colorectal and breast cancer in postmenopausal women.

Authors:  Marian L Neuhouser; JoAnn E Manson; Amy Millen; Mary Pettinger; Karen Margolis; Elizabeth T Jacobs; James M Shikany; Mara Vitolins; Lucile Adams-Campbell; Simin Liu; Erin LeBlanc; Karen C Johnson; Jean Wactawski-Wende
Journal:  Am J Epidemiol       Date:  2012-02-22       Impact factor: 4.897

8.  Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Authors:  D Michal Freedman; Shih-Chen Chang; Roni T Falk; Mark P Purdue; Wen-Yi Huang; Catherine A McCarty; Bruce W Hollis; Barry I Graubard; Christine D Berg; Regina G Ziegler
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-04-01       Impact factor: 4.254

9.  Genome-wide association study of circulating vitamin D levels.

Authors:  Jiyoung Ahn; Kai Yu; Rachael Stolzenberg-Solomon; K Claire Simon; Marjorie L McCullough; Lisa Gallicchio; Eric J Jacobs; Alberto Ascherio; Kathy Helzlsouer; Kevin B Jacobs; Qizhai Li; Stephanie J Weinstein; Mark Purdue; Jarmo Virtamo; Ronald Horst; William Wheeler; Stephen Chanock; David J Hunter; Richard B Hayes; Peter Kraft; Demetrius Albanes
Journal:  Hum Mol Genet       Date:  2010-04-23       Impact factor: 6.150

10.  Association between pre-diagnostic circulating vitamin D concentration and risk of colorectal cancer in European populations:a nested case-control study.

Authors:  Mazda Jenab; H Bas Bueno-de-Mesquita; Pietro Ferrari; Franzel J B van Duijnhoven; Teresa Norat; Tobias Pischon; Eugène H J M Jansen; Nadia Slimani; Graham Byrnes; Sabina Rinaldi; Anne Tjønneland; Anja Olsen; Kim Overvad; Marie-Christine Boutron-Ruault; Françoise Clavel-Chapelon; Sophie Morois; Rudolf Kaaks; Jakob Linseisen; Heiner Boeing; Manuela M Bergmann; Antonia Trichopoulou; Gesthimani Misirli; Dimitrios Trichopoulos; Franco Berrino; Paolo Vineis; Salvatore Panico; Domenico Palli; Rosario Tumino; Martine M Ros; Carla H van Gils; Petra H Peeters; Magritt Brustad; Eiliv Lund; María-José Tormo; Eva Ardanaz; Laudina Rodríguez; Maria-José Sánchez; Miren Dorronsoro; Carlos A Gonzalez; Göran Hallmans; Richard Palmqvist; Andrew Roddam; Timothy J Key; Kay-Tee Khaw; Philippe Autier; Pierre Hainaut; Elio Riboli
Journal:  BMJ       Date:  2010-01-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.